Industry: Pharmaceuticals, Biotechnology
PDL BioPharma, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life threatening illnesses. The company currently markets and sells a portfolio of leading products in the acute-care hospital setting in the United States and Canada and generates royalties through licensing agreements with top-tier biotechnology and pharmaceutical companies based on its pioneering humanized antibody technology. Currently, PDL BioPharma’s diverse late-stage product pipeline includes six investigational compounds in Phase 2 or Phase 3 clinical development for hepatorenal syndrome, inflammation and autoimmune diseases, cardiovascular disorders and cancer. ( www.pdl.com )
PDL BioPharma , Inc.
9450 Winnetka Ave. N.
Brooklyn Park, Minnesota 55445
USA
Tel: (763) 255-5000
Fax: (763) 255-5474